Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
LOUISIANA WHOLESALE DRUG COMPANY, INC. v. BECTON DICKINSON & COMPANY, INC.
Case Number:
2:05-cv-01602
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Berger Montague
- Cohn Lifland
- Hunton Andrews
- Lowenstein Sandler
- NastLaw
- Paul Weiss
- Stern Kilcullen
- Stone Conroy LLC
Companies
Sectors & Industries:
-
August 01, 2013
Becton Dickinson Pays $22M To Settle Syringe Antitrust Suits
Becton Dickinson & Co. has struck a $22 million settlement agreement with hospitals and pharmacies whose class actions accused the New Jersey-based medical technology company of stifling competition from other hypodermic product makers, the company said in a Tuesday filing with the U.S. Securities and Exchange Commission.
-
April 15, 2013
Attorneys Reap $17.2M In Becton Antitrust Dispute
A New Jersey federal judge on Friday awarded $17.2 million in fees and expenses to attorneys representing a class of medical supply distributors and other direct purchasers who accused medical supplier Becton Dickinson & Co. of monopolizing the national market for hypodermic needles.
-
November 16, 2012
Long-Delayed $45M Becton Antitrust Deal Wins Court OK
Following more than three years of delay, a New Jersey federal judge on Thursday signed off on a $45 million settlement to resolve claims that medical supplier Becton Dickinson & Co. monopolized the national market for hypodermic needles.